|
|
|
|
| LEADER |
01000caa a22002652 4500 |
| 001 |
CTG004859960 |
| 003 |
DE-627 |
| 005 |
20230425165628.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
210507s2020 xx |||||o 00| ||eng c |
| 035 |
|
|
|a (DE-627)CTG004859960
|
| 035 |
|
|
|a (UBBS_Klinische_Studien_WHO)ACTRN12607000425493
|
| 035 |
|
|
|a (UBBS_Klinische_Studien_WHO)Nil Known
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 245 |
1 |
0 |
|a Evaluation of diallertest® in food intolerant children with and without autistic spectrum disorder (ASD)
|b Evaluation of diallertest® in food intolerant children with and without autistic spectrum disorder (ASD)
|
| 264 |
|
1 |
|c 2020
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a Computermedien
|b c
|2 rdamedia
|
| 338 |
|
|
|a Online-Ressource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 22-08-2007, Last updated: 2022-11-24
|
| 650 |
|
4 |
|a Medical Condition: Clinical evaluation of Diallertest Patch Test used for diagnosis of delayed hypersensitivity to milk and wheat proteins. Allergen concentration is below TGA requirement for Registration. Product is registered in France and United Arab Emirates.Product Information Sheet is attached.; Clinical evaluation of Diallertest Patch Test used for diagnosis of delayed hypersensitivity to milk and wheat proteins. Allergen concentration is below TGA requirement for Registration. Product is registered in France and United Arab Emirates.Product Information Sheet is attached.;Skin - Other skin conditions;Diet and Nutrition - Other diet and nutrition disorders
|
| 650 |
|
4 |
|a Study Type: Interventional
|
| 650 |
|
4 |
|a Recruitment Status: Completed
|
| 650 |
|
4 |
|a 610
|
| 773 |
0 |
8 |
|i Enthalten in
|t WHO International Clinical Trials Registry Platform
|g (2020) vom: 13. Jan.
|
| 773 |
1 |
8 |
|g year:2020
|g day:13
|g month:01
|
| 856 |
4 |
0 |
|u https://anzctr.org.au/ACTRN12607000425493.aspx
|z kostenfrei
|3 Volltext
|
| 912 |
|
|
|a GBV_CTG
|
| 912 |
|
|
|a SSG-OLC-PHA
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|j 2020
|b 13
|c 01
|
Klinische Studie